2OH-BNPP1 is an inhibitor of the kinase activity of BUB1 (budding uninhibited by benzimidazoles-1, BUB1 Mitotic Checkpoint Serine/Threonine Kinase) that can be used for the treatment of cancer.
2OH-BNPP1 inhibits the kinase activity of Bub1 in human cells, as evidenced by the reduced phosphorylation of H2A, a known Bub1 substrate, producing checkpoint defects of cells.[2]
[1] Shyam Nyati, et al. Sci Signal. 2015 Jan 6;8(358):ra1. [2] Jia L, et al. Nat Commun. 2016 Feb 25;7:10818.
















